Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The relationship between producin...
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bioanalysis has undergone signif...
作为 Healius 网络的一部分，Agilex Biolabs 公司继续进行全球扩张和企业发展，斯蒂芬-麦金太尔（Stephen McIntyre）被选为公司首席执行官。
ddPCR technology provides an opportunity to streamline research and development processes, saving time and money. Digital dropl...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agilex has extensive experience de...
Agilex has extensive experience developing and validating like-binding assays for specific immune-oncology therapeutics. From a...
Come to Our EBF Session in Barcelona to Hear how Agilex Can Make Your PK Data SPARCL SPARCL stands for Spatial Proximity Analyt...
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology studies? There are many ben...
